Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2004 / Cilt: 38 - Sayı: 3

Bone mineral density in patients receiving isotretinoin and acitretin

İzotretinoin ve asitretin kullanan hastalarda kemik mineral yoğunlukları

Pages
191–194
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Short term (six months) isotretinoin and acitretin with a low dose of 0.5 mg/kg/day were not due to osteoporosis at the lumbar spine and the hip.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and design: Isotretinoin and acitretin, known as retinoids, are synthetic derivaties of vitamin A.
📊
Key Findings & Data:Material and Method: Nineteen patients who received 0.5 mg/kg/day dose of acitretin (n=16) and isotretinoin (n=3) were included in this study.
💡
Conclusion & Impact:Conclusion: Short term (six months) isotretinoin and acitretin with a low dose of 0.5 mg/kg/day were not due to osteoporosis at the lumbar spine and the hip.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and design: Isotretinoin and acitretin, known as retinoids, are synthetic derivaties of vitamin A. They have been known to cause a variety of skeletal side effects. The aim of the study was to determine whether the patients receiving synthetic retinoids are under the risk of osteoporosis. Material and Method: Nineteen patients who received 0.5 mg/kg/day dose of acitretin (n=16) and isotretinoin (n=3) were included in this study. Bone mineral density (g/cm2) of left hip (neck, trochanter) and lumbar spine (L2-L4) were measured by Dual Energy X-Ray Absorptiometry before and at the sixth month of the therapy. Results: We didn’t find statistically significant difference in bone mineral density (p>0.05). Conclusion: Short term (six months) isotretinoin and acitretin with a low dose of 0.5 mg/kg/day were not due to osteoporosis at the lumbar spine and the hip.

Özet

İzotretinoin ve asitretin vitamin A türevi sentetik retinoidler olup, iskelet sistemi üzerine yan etkilerinin olduğu bilinmektedir. Çalışmamızda oral sentetik retinoid kullanan hastaların kemik mineral yoğunluğu ölçümlerini yaparak osteoporoz riski taşıyıp taşımadıklarını tespit etmeyi amaçladık. Çalışmaya 0.5 mg/kg/gün dozunda 16’sı asitretin ve 3’ü izotretinoin alan toplam 19 hasta alındı. Tedavi öncesinde ve 6. ayın sonunda lomber vertebraların (L2-L4) ve sol kalçanın (femur boynu ve trokanterik bölge) kemik mineral yoğunluğu ölçümleri (g/cm2) Dual Energy X-Ray Absorbsiometri ile yapıldı. Tedavi öncesi ve sonrası kemik mineral yoğunluğu ölçümlerinde istatistiksel olarak anlamlı bir fark saptanmadı (p>0.05). Sonuç olarak, düşük doz (0,5 mg/kg/gün) ve kısa dönem (6 ay) izotretinoin ve asitretinin kullanımının, lomber vertebra ve kalçada osteoporoz yapıcı etkisinin olmadığı bulundu.

🔖

Cite This Article

CANTÜRK, T., SARAÇ, N., ALAYLI, G., TOSUN, C. F., AYDIN, F., CANTÜRK, F., AKYOL, Y. (2022). Bone mineral density in patients receiving isotretinoin and acitretin. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 38 - Sayı: 3, 191–194. https://ajindex.com/articles/622223

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kaplan G, Haettich B: Rheumatological symptoms due to retinoids. Baillieres Clin Rheumatol 1991;5:77-97
  2. Halkier- Sorensen L, Andresen J: A retrospective study of bone changes in adults treated with etretinate. J Am Acad Dermatol 1989;20:83-87
  3. DiGiovanna JJ: Isotretinoin effects on bone. J Acad Dermatol 2001;45:176-182
  4. Kanis JA, Melton LJ, Christiansen C, et al: The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141
  5. Atakan N, Karaduman A: Retinoidler. İlaç ve Tedavi Dergisi 1992;5:7-12
  6. DiGiovanna JJ, Helfgott RK, Gerber LH, Peck GL: Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. N Engl J Med 1986;315:1177-1182
  7. Van Dooren-Greebe RJ, Lemmens JA, DE Boo T, et al: Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities. Br J Dermatol 1996;134:71-76
  8. Scheven BA, Hamilton NJ: Retinoic acid and 1, 25-dihydroxyvitamin D3 stimulate osteoclast formation by different mechanisms. Bone 1990;11:53-59
  9. DiGiovanna JJ, Solitto RB, Abangan DL, et al: Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 1995;131:1263-1267
  10. Okada N, Nomura M, Morimoto S, et al: Bone mineral density of the lumbar spine in psoriatic patients with long term etretinate therapy. J Dermatol 1994;21:308-311
  11. Mcmullen EA, McCarron P, Irvine D, et al: Clin and Exp Dermatol 2003;28:307-309
  12. Margolis DJ, Attie M, Leyden JJ: Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 1996;132:769-774
  13. Leachman SA, Insogna KL, Katz L, et al: Bone densities in patients receiving isotretinoin for cystic acne. Arch Dermatol 1999;135:961-965.